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Profiling analysis of long non-
coding RNAs in early postnatal 
mouse hearts
Xiongshan Sun1,2,*, Qi Han1,2,*, Hongqin Luo1,2, Xiaodong Pan1,2, Yan Ji1,2, Yao Yang1,2, 
Hanying Chen3, Fangjie Wang1,2, Wenjing Lai1,2, Xiao Guan1,2, Qi Zhang1,2, Yuan Tang1,2, 
Jianhong Chu5, Jianhua Yu4, Weinian Shou1,2,3, Youcai Deng1,2 & Xiaohui Li1,2
Mammalian cardiomyocytes undergo a critical hyperplastic-to-hypertrophic growth transition at 
early postnatal age, which is important in establishing normal physiological function of postnatal 
hearts. In the current study, we intended to explore the role of long non-coding (lnc) RNAs in this 
transitional stage. We analyzed lncRNA expression profiles in mouse hearts at postnatal day (P) 1, 
P7 and P28 via microarray. We identified 1,146 differentially expressed lncRNAs with more than 
2.0-fold change when compared the expression profiles of P1 to P7, P1 to P28, and P7 to P28. The 
neighboring genes of these differentially expressed lncRNAs were mainly involved in DNA replication-
associated biological processes. We were particularly interested in one novel cardiac-enriched lncRNA, 
ENSMUST00000117266, whose expression was dramatically down-regulated from P1 to P28 and was 
also sensitive to hypoxia, paraquat, and myocardial infarction. Knockdown ENSMUST00000117266 
led to a significant increase of neonatal mouse cardiomyocytes in G0/G1 phase and reduction in G2/M 
phase, suggesting that ENSMUST00000117266 is involved in regulating cardiomyocyte proliferative 
activity and is likely associated with hyperplastic-to-hypertrophic growth transition. In conclusion, our 
data have identified a large group of lncRNAs presented in the early postnatal mouse heart. Some of 
these lncRNAs may have important functions in cardiac hyperplastic-to-hypertrophic growth transition.
Promoting cardiomyocyte regenerative potential has been one of recent interests for combating heart failure. 
Numerous recent studies have shown that, in mammalian hearts, cardiomyocytes have a higher rate of prolif-
eration to meet the demand of cardiac growth at mid-gestation. They gradually lose their proliferative activi-
ties towards late-gestation, and nearly completely withdraw from cell cycle after the first week post parturition. 
Simultaneously, the early postnatal hearts switch to hypertrophic growth1–3. This phenomenon is also consistent 
with a recent study that 1-day old neonatal mouse hearts remain capability to recover from partial ventricular 
apex resection or myocardial ischemia, while this potential is lost after postnatal day (P) 7, likely due to the loss 
of cardiomyocyte proliferative activity by P74,5. Unraveling the underlying mechanism will provide great insight 
of cardiac transition from hyperplastic growth to hypertrophic growth, which will likely help to develop novel 
regenerative therapies for heart failure.
Micro (mi) RNAs, such as miR-195 and miR-17-92, have important roles in neonatal heart development via 
their regulation of checkpoint kinase 1 (Chek1) and phosphatase and tensin (PTEN), respectively, which are critical 
in regulating cardiomyocyte cell cycle activity6–8. This earlier work promoted us to explore whether other regu-
latory RNAs, such as long non-coding (lnc) RNAs, were also involved in neonatal heart development. LncRNAs 
exert various biological effects, participating in alternative splicing, gene imprinting, gene transcription, cell cycle 
and apoptosis, and other key biological processes9. Many lncRNAs are expressed in a unique spatial and tem-
poral pattern during development, indicating that they are highly relevant to the regulation of developmental 
processes10,11. So far, several lncRNAs have been identified as functional regulators of cardiac development and 
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pathogenesis of heart failure and cardiomyopathies12–18. However, whether these lncRNAs are associated with 
hyperplastic-to-hypertrophic growth transition is largely unknown.
In the present study, we performed profiling analyses on lncRNA expression in early postnatal hearts 
using Mouse LncRNA Microarray v2.0 Service from Arraystar, Inc (Agilent Technologies). We identified 
over thousands of lncRNAs via bioinfomatic analysis that were differentially expressed from P1 to P28. We 
then validated 10 lncRNAs by qRT-PCR for their expression levels and tissue specificities. Among them, we 
focused on one novel cardiac-enriched lncRNA, ENSMUST00000117266, which was likely involved in the 
hyperplastic-to-hypertrophic growth transition via its role in regulating cardiomyocyte proliferation.
Results
LncRNA profiling in early postnatal murine heart. To identify the differentially expressed lncR-
NAs in early postnatal hearts, lncRNA microarray was performed by using C57BL/6 J mouse hearts harvested 
at P1, P7 and P28. In total, the signals of 18,158 lncRNAs from authoritative data sources from University of 
California Santa Cruz, RefSeq, Ensembl and other related literatures were captured in lncRNA microarray, with 
most of their length between 200 to 3000 nucleotides (Fig. 1a and Supplementary Table S1). These lncRNAs 
included intergenic, exon sense-overlapping, natural antisense, intronic-overlapping, bidirectional and intronic 
sense-overlapping transcripts, among which intergenic lncRNAs were over 10,000 (Fig. 1b). A total of 765 
or 4,855 lncRNAs were differentially expressed with more than 2.0-fold change (false discovery rate (FDR) 
< 0.05) between P1 and P7 or between P7 and P28, respectively, as shown by volcano plot analysis (Fig. 1c and 
Supplementary Table S2). After quantile normalization of the raw data for these three time points, any lncRNA 
with more than 2.0-fold change between any two groups was counted. Totally, 1,146 lncRNAs were found to meet 
the criteria (FDR < 0.05). Among these 1,146 differentially expressed transcripts, 253 lncRNAs were gradually 
upregulated, while 487 lncRNAs were gradually downregulated. As compared to P1 mouse heart, 315 lncRNAs 
were upregulated at P7 and then downregulated at P28; while only 91 lncRNAs were downregulated at P7 and 
then upregulated at P28 (Fig. 1d). Of note, when the fold change between P1 and P28 was set to over 10.0, there 
were still 107 downregulated lncRNAs and 46 upregulated lncRNAs (Supplementary Table S3).
The Series Test of Cluster (STC) of lncRNA and mRNA expression profiles. To further charac-
terize lncRNA and mRNA expression profiles, we set up 16 expression model profiles for the 1,146 differen-
tially expressed lncRNAs and 1,358 mRNAs in microarray by using STC method in STEM software. Each profile 
represents an expression model containing a group of lncRNAs or mRNAs with a similar expression pattern, 
respectively. 7 expression patterns of lncRNA and 7 expression patterns of mRNA showed statistically signifi-
cance, respectively (p < 0.05) (Fig. 2a,b and Supplementary Table S4). Surprisingly, all of the 7 significant lncRNA 
expression patterns also existed in the significant mRNA expression profiles. We next analyzed the total number 
of lncRNAs or mRNAs in each significant expression pattern, respectively. Interestingly, we found that 436 lncR-
NAs and 498 mRNAs were assigned to Profile #15, which is the most significant pattern in both lncRNA and 
mRNA profile (Fig. 2c,d, top left panel). The expression of lncRNAs in Profile #15 remained temporally stable 
from P1 to P7 but rapidly declined at P28. This group of lncRNAs might be involved in the early postnatal heart 
development, as this period represents a process that the capacity of cardiomyocyte proliferation soon disappears. 
We also found more similar assigned number of both lncRNAs and mRNAs in the same pattern, such as Profile 
#9, 11, 14 and 4. The closer similarity between lncRNA and mRNA expression profiles suggested that lncRNAs 
might be tightly involved in mRNA expression in the early postnatal heart.
Hierarchical clustering of differentially expressed lncRNAs and neighboring gene mRNAs. It 
has been anticipated that lncRNA prefers to be located at the neighboring coding genes and regulates the 
expression of these genes19–21. Totally, we identified 879 pairs of lncRNA-neighboring coding gene partners 
(Supplementary Table S5), 59 of which showed differential expression in both lncRNAs and their neighboring 
coding genes (Fig. 3a and Supplementary Table S6). We also listed the positive and negative lncRNA-mRNA 
pairs whose coding genes were reported to be involved in cardiac development and function (Fig. 3b,c). For 
example, uc008ffq.1 along with its neighboring gene Collagen and calcium-binding EGF-like domain 1 (Ccbe1) 
and uc008kgz.1 along with its neighboring gene Protein phosphatase 1, regulatory (inhibitor) subunit 1C 
(Ppp1r1c)22 were consistently and gradually upregulated from P1 to P28 (Fig. 3b, left and middle panel). In addi-
tion, uc007lay.1 and its neighboring gene Igf2 mRNA-binding protein 1 (Igf2bp1)23 were both gradually down-
regulated from P1 to P28 (Fig. 3b, right panel). The similar expression pattern of lncRNA and mRNA indicated 
positive correlation. Protein phosphatase 1, regulatory (inhibitor) subunit 1B (Ppp1r1b)24 or versican (Vcan)25 
showed gradually downregulation or upregulation from P1 to P28, opposite to the expression patterns of their 
neighboring lncRNAs uc007lgb.1 and uc007rjm.1, respectively (Fig. 3c, left and middle panel). In addition, 
ENSMUST00000127169 was rapidly increased from P1 to P7 but gradually declined from P7 to P28, opposite 
to its neighboring gene proteolysis of human protein tyrosine kinase 7 (Ptk7)26 (Fig. 3c, right panel). These data 
suggested a potential negative regulation. Nuclear lncRNAs usually transcriptionally or epigenetically regulate 
gene expression18, while lncRNAs in cytosol are more likely to modulate gene expression post-transcriptionally15. 
Therefore, we also determined the nuclear or cytosolic distribution of these 6 lncRNAs presented in Fig. 3b,c. 
Data showed that uc008ffq.1 was mainly located in nucleus, indicating its potency to transcriptionally regulate 
Ccbe1. Meanwhile, the other 5 lncRNAs, located equally in nucleus and cytoplasm, may modulate their neighbor-
ing genes either transcriptionally or post-transcriptionally (Supplementary Fig. S1).
Gene Ontology (GO) and pathway analysis. GO analysis of the neighboring coding genes related to 
the 1,146 differentially expressed lncRNAs showed the significantly changed GO terms for the neighboring 
gene expression patterns were mainly involved in DNA synthesis-associated process, such as DNA binding, 
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Figure 1. Global description of lncRNAs expressed in neonatal mouse heart. 18,158 lncRNAs were detected 
by using microarray technique. (a) The pie chart shows the length distribution of lncRNAs. (b) The Number 
of lncRNA transcripts per subcategory sorted by their positions relative to nearby coding genes. (c) Volcano 
plot of fold changes and corresponding FDR values for each lncRNA after comparison of P7 and P1 heart (left 
panel) or P28 and P7 heart (right panel), respectively. The red points represent lncRNAs with fold change ≥ 2.0 
and FDR < 0.05. The black points represent lncRNAs with fold change < 2.0 or FDR ≥ 0.05. (d) Heat maps show 
the hierarchical clustering analysis of the 1,146 differentially expressed lncRNAs with four different expression 
patterns. Each row represents the same lncRNA and each column represents the same sample. The expression 
intensity of each lncRNA in one sample is represented in shade of red or green, indicating its expression level 
above or below the median expression intensity across all samples, respectively. One-way ANOVA for (c and d). 
(n = 3 samples per time point).
www.nature.com/scientificreports/
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DNA-templated transcription and cell cycle (Fig. 4a), which might be important for cardiomyocyte proliferation. 
Pathway analysis identifying the enriched pathways for the neighboring coding genes showed that some of them 
were involved in development and metabolism-associated pathways (Fig. 4b), such as AMP-activated protein 
kinase (AMPK)27.
Microarray validation by qRT-PCR. To validate the microarray data, we chose 5 most consistently 
upregulated and 5 most consistently downregulated lncRNAs from P1 to P28 with the highest fold changes, 
Figure 2. STC analysis of differentially expressed lncRNAs and mRNAs in microarray. (a,b) Sixteen model 
profiles were utilized to analyze the expression patterns of 1,146 differentially expressed lncRNA transcripts 
(a) and 1,358 differentially expressed coding genes (b), respectively. Each box represents a different model 
expression profile. The p value and corresponding model profile number were listed in upper and lower corner 
of each profile box, respectively. Red or blue boxes represent model expression profile with p < 0.05 or with 
p ≥ 0.05, respectively. The horizontal and vertical axes represent time points and gene expression levels after 
Log normalized transformation, respectively. (c,d) 7 model expression profiles of lncRNA transcripts (c) and 
coding genes (d) with statistically significant (p < 0.05) are shown, respectively. Model expression profile 
number and the number of genes assigned to its corresponding profile are shown on the top of each profile. The 
horizontal and vertical axes represent indicated time points and the time series of gene expression levels after 
Log normalized transformation, respectively. Fisher exact test for (a and b).
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Figure 3. The expression levels of lncRNAs and neighboring gene mRNAs within 300 kb. (a) Heat maps 
show the expression levels of 59 differentially expressed lncRNAs (upper panel) and their corresponding 
differentially expressed neighboring gene mRNAs (lower panel) at three indicated time series. Each row 
represents one lncRNA (top) or one mRNA (bottom), respectively, and each column represents one sample. 
Each line indicates a lncRNA-mRNA pair. A red line represents a positive associated lncRNA-mRNA pair 
and a blue line represents a negative associated lncRNA-mRNA pair, respectively, while a black line means no 
obvious expression relevance between a lncRNA and its neighboring coding gene. The expression value of each 
lncRNA in one sample is represented in shade of red or green, indicating its expression level above or below 
the median expression value across all samples, respectively. (b) The normalized intensity of uc008ffq.1-Ccbe1, 
uc008kgz.1-Ppp1r1c and uc007lay.1-Igf2bp1 in the microarray data. (c) The normalized intensity of uc007lgb.1-
Ppp1r1b, uc007rjm.1-Vcan and ENSMUST00000127169-Ptk7 in the microarray data. #p < 0.05, ##p < 0.01 and 
###p < 0.001 vs. P1 for lncRNAs. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. P1 for mRNAs. One-way ANOVA for 
(b and c). (n = 3 samples per time point).
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respectively, and analyzed their expression levels in P1, P7 and P28 mouse hearts by qRT-PCR (Fig. 5a and 
Supplementary Fig. S2). The differential gene expression levels by qRT-PCR was in agreement with that found in 
the microarray data sets. From the array data, we found three differentially expressed neighboring genes, Ppp1r1c 
(associated with uc008kgz.1), AW112010 (associated with uc008grn.1) and SAP30-like (Sap30l) (associated with 
ENSMUST00000117266), showed consistent expression patterns with their neighboring lncRNAs among these 
10 lncRNAs (Data not shown), which were also validated by qRT-PCR (Supplementary Fig. S3).
As many lncRNAs had specific tissue expression pattern19, we next explored whether the above-validated 
lncRNAs showed a cardiac specificity. We analyzed heart, kidney, blood vessel, skeletal muscle, liver and small 
intestine to determine the cardiac-enriched lncRNAs via qRT-PCR. The age of mouse chosen for lncRNA tissue 
specificity was based on the higher cardiac expression level of associated lncRNAs at P1 or P28. Subsequently, 
we identified one novel lncRNA, ENSMUST00000117266, highly expressed in the hearts as compared to 
other tissues (Fig. 5b). The data was acquired and normalized by using 18S and Gapdh as internal controls 
(Supplementary Fig. S4).
Functional analysis of ENSMUST00000117266. ENSMUST00000117266 is located at the reverse 
strand of chromosome 11 and stretches from 57,948,729 to 57,949,085. To explore the potential biological role 
of ENSMUST00000117266, we conducted signaling network analysis which provided the potential information 
for co-expressed genes of ENSMUST00000117266 (Fig. 6a). A total of 81 genes were involved in the subnetwork 
of ENSMUST00000117266, among which 44 were coding genes (Supplementary Table S7). In this subnetwork, 
high mobility group AT-hook 2 (Hmga2) was involved in cardiogenesis and normal cardiac development28, while 
Ccbe1 was associated with cardiac and lymphatic progenitor lineage specification at early developmental stage29. It 
was noteworthy that Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (Cited1), 
a transcriptional cofactor participating in embryonic development and embryo viability, was also involved in this 
subnetwork30. These data indicated a potential role of ENSMUST00000117266 in neonatal heart development.
To explore whether the expression level of ENSMUST00000117266 could be affected by cellular stress, we 
first applied an in vitro model of cardiomyocyte exposure to hypoxia to recapitulate reduced cardiomyocyte pro-
liferation and increased cellular size31. ENSMUST00000117266 expression showed a significant downregulation 
in cardiomyocytes after 6-hour exposure to hypoxia (Fig. 6b). We also confirmed this finding by using an in vivo 
Figure 4. GO and pathway analysis of differentially expressed neighboring coding genes in neonatal mouse 
heart. (a,b) GO (a) and pathway (b) analysis of the neighboring coding genes corresponding to differentially 
expressed lncRNAs. The vertical and horizontal axes represent the biological process/pathways and − Log10 (p value) 
of the corresponding biological process/pathways, respectively. The top 10 significant involved GO items and 
pathways (p < 0.001) are shown. Fisher exact test for (a and b).
www.nature.com/scientificreports/
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model by stimulating neonatal mice with paraquat, a reactive oxygen species (ROS) generator which is reported 
to induce the shift from hyperplastic-to-hypertrophic growth in neonatal heart (Fig. 6c)3. In addition, we also 
determined the expression of ENSMUST00000117266 in a mouse ischemic cardiac disease model. Surprisingly, 
ENSMUST00000117266 was significantly upregulated after 2 days (d) but soon downregulated after 3 d of 
Figure 5. Validation of lncRNA expression in microarray data by real time qRT-PCR. (a) The expression 
levels of 5 consistently upregulated lncRNAs (left panel) and 5 consistently downregulated lncRNAs (right 
panel) during neonatal mouse heart development were validated by real time qRT-PCR. (b) The expression 
levels of the above-validated lncRNAs in different mouse tissues that contain smooth muscle cells were 
determined by real time qRT-PCR. Data are normalized to Gapdh. Data are shown as mean ± S.D. *, ** and 
***indicate p < 0.05, p < 0.01 and p < 0.001, respectively, which denote statistical comparison between the two 
marked groups. One-way ANOVA for (a) (post hoc: LSD multiple comparison test for AK047066, uc008kgz.1, 
uc008grn.1, ENSMUST00000140716, uc009kob.1, ENSMUST00000136359, ENSMUST00000117266 and 
ENSMUST00000149974; Dunnett T3 multiple comparison test for ENSMUST00000153057 and AK009349) 
and (b) (post hoc: LSD multiple comparison test). (n = 3 samples per time point).
www.nature.com/scientificreports/
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Figure 6. Gene co-expression subnetwork of ENSMUST00000117266 and its role in cardiomyocyte 
proliferation. (a) Co-expression subnetwork of ENSMUST00000117266. (b) Cardiomyocytes were cultured 
under normoxic or hypoxic conditions for 6 hours and the expression of ENSMUST00000117266 was 
determined by real time qRT-PCR. (c) 0.9% saline solution or paraquat (5 mg/kg) was daily administrated 
subcutaneously to neonatal mouse for 3 days after birth and the expression of ENSMUST00000117266 was 
determined in heart harvested at P3. (d) The expression of ENSMUST00000117266 at indicated time point 
after sham or MI surgery was determined by qRT-PCR. (e) The protein expression of LAMIN A and GAPDH 
in nucleus and cytoplasm of P1 mouse cardiomyocytes was analyzed by immunoblotting. The RNA levels of 
Gapdh and ENSMUST00000117266 in nucleus and cytoplasm of P1 mouse cardiomyocytes were analyzed by 
qRT-PCR. (f) Cell cycle analysis of primary mouse cardiomyocytes after ENSMUST00000117266 knockdown 
by using PI staining. Representative histograms and statistical data are shown. (g) The mRNA expressions 
of Hand1, Larp1 and Sap30l in primary mouse cardiomyocytes were assessed by qRT-PCR after 48-hours 
ENSMUST00000117266 siRNA (left) or ASO (right) transfection. Data are normalized to Gapdh. Data are 
shown as mean ± S.D. *p < 0.05, **p < 0.01 and ***p < 0.001 denote statistical comparison between the two 
marked groups, respectively. T approximation test for (b) unpaired two-tailed Student’ t-test for (d,f and g); 
paired two-tailed Student’ t-test for (c and e). (n = 3 cultures per group in (b and e) n = 3 samples per group in 
(c); n = 4 samples per group in (d); n = 4 cultures per group in (f); n = 5 cultures per group in (g).
www.nature.com/scientificreports/
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myocardial infarction (MI) surgery (Fig. 6d)32. This finding suggested that ENSMUST00000117266 participated 
in the early adaptive process responding to the deleterious stress in ischemic cardiac diseases.
qRT-PCR analysis of subcellular distribution of ENSMUST00000117266 in neonatal mouse cardiomyocytes 
showed that ENSMUST00000117266 equally located in both nucleus and cytoplasm (Fig. 6e). To further deter-
mine the role of ENSMUST00000117266 in the proliferation of cardiomyocytes, we utilized the siRNA strat-
egy to knockdown ENSMUST00000117266. We found the percentage of cardiomyocytes in G0/G1 phase of cell 
cycle was significantly increased but the percentage of cardiomyocytes in G2/M phase was significantly decreased 
(Fig. 6f), suggesting that ENSMUST00000117266 was involved in regulating cardiomyocyte proliferative activity. 
In addition, the mRNA expression level of a neighboring coding gene of ENSMUST00000117266, Sap30l, which 
was previously shown to regulate hemoglobin synthesis and erythropoiesis in early development33, was also sig-
nificantly downregulated (Fig. 6g, left panel). However, the expression of two other neighboring genes, heart 
and neural crest derivatives expressed transcript 1 (Hand1) and La ribonucleo protein domain family member 1 
(Larp1), was almost unchanged after ENSMUST00000117266 knockdown. To further confirm our conclusion, 
we also utilized antisense oligonucleotides (ASOs) method, which targets both pre-mRNA and mature mRNA34. 
Consistently, we also observed decreased mRNA level of Sap30l after ENSMUST00000117266 knockdown 
(Fig. 6g, right panel). These results suggested that ENSMUST00000117266 was likely to function as a regulator of 
cardiomyocyte proliferative activity via its neighboring coding gene Sap30l.
Discussion
Heart development is a multi-factorial and complex process involving many signaling pathways that are regulated 
by growth factors, cytokines, and cardiogenic transcription factors. Non-coding genes constitute the majority of 
human genome while coding genes only account for 1.2%35. Previously, several elegant studies have identified 
cardiac-enriched lncRNAs in cardiovascular lineage commitment12, embryonic heart development18,36–39, and 
cardiovascular diseases such as cardiac hypertrophy and heart failure16,40. Our current study is focused on the 
expression profiles of lncRNAs in the hearts during the early postnatal growth stage, which is associated with 
the critical transition from hyperplastic to hypertrophic growth with dynamic cellular processes orchestrated 
by a complex signal network1–3. Characterizing the lncRNA expression profiles during this transition offers us a 
new horizon to better understand the complex regulatory network for heart development and maturation. The 
lncRNA expression profile in the early postnatal hearts also bridges between fetal and adult heart physiology.
Previous studies identified 3,997 differentially expressed lncRNAs (fold change ≥ 2.0) between embryonic 
and adult mouse heart37. The present study observed total 1,146 differentially expressed lncRNAs (fold change 
≥ 2.0) in mouse hearts at three time points P1, P7 and P28, which covered the period from neonatal age to post 
lactation stage. Even if the fold change between P1 and P28 was set to over 10.0, there were still 153 significantly 
changed lncRNAs, 10 of which were found to be differentially expressed between embryonic and adult mouse 
heart37. These highly dynamic changes of lncRNA expressions during the early postnatal stage suggested their 
crucial roles in cardiac adaptation response after the birth, such as to the oxygenation state, neuroendocrine stim-
ulation41, changes in hemodynamics42, and lactation3,43. GO and pathway analysis of neighboring genes showed 
that the major biological processes and pathways were predominantly associated with cardiac development and 
growth, including cell cycle regulation, DNA-templated transcription, as well as AMPK signaling pathway as 
previously reported27 and also in consistent with recent studies that lncRNAs in developing embryos were mainly 
involved in cell cycle regulation, cell differentiation, and cell fate commitment38. Furthermore, our STC analy-
sis showed that lncRNAs in Profile #9 and #4 were persistently downregulated from P1 to P28, suggesting that 
these transcripts might mainly act on the embryonic heart development. LncRNAs in Profile #11, #14 and #1 
were expressed with the highest level at P28, which supported their roles in maintaining adult heart function. 
Interestingly, our data also revealed 44.6% of total differentially expressed lncRNAs that were maintained higher 
expression levels at P1 and P7 but dramatically down-regulated to a near undetected level at P28. We speculated 
that these lncRNAs might play a more specific role in the period of early postnatal heart maturation and likely 
mediating the transition of cardiac hyperplastic growth to hypertrophic growth.
Several lncRNAs are involved in heart development and function by regulating neighboring genes, such as 
the pair of Fendr-Foxf1 and Kcnq1ot1-Kcnq114,18. Our data also showed numerous lncRNA-mRNA co-expressed 
pairs either in positive or negative manner. The positive pair of uc008ffq.1-Ccbe1 might be involved in early car-
diac development via modulating migration and proliferation of cardiac precursors cells29,44. Another positive 
pair, uc008kgz.1-Ppp1r1c, might be involved in maintaining normal function of cardiomyocytes22. The rapid 
expression change of ENSMUST00000127169 from P1 to P7 and P7 to P28 suggests its potential role in early 
heart development through negatively regulating the mRNA expression of Ptk726. Additionally, we also found a 
portion of overlapping sequences existed in two pairs of lncRNA-mRNA partners (ENSMUST00000127169-Ptk7 
and uc008ffq.1-Ccbe1), which further suggests the potential interactions between the lncRNAs and their corre-
sponding neighboring coding genes. In our present study, we also found several lncRNAs that were previously 
reported to be involved in heart development and function might also participate in the regulation of postnatal 
heart maturation. For example, Bvht (AK143260), known as a lncRNA inducing cardiac lineage commitment 
during embryonic period12, was upregulated more than 2.0-fold in P28 mouse heart compared to that in P1. 
This suggested that Bvht might also be involved in the fetal-to-adult physiology switching in the early postnatal 
hearts. Another well-known lncRNA, H19 (ENSMUST00000149974), has been previously identified as a typical 
transcript participating in cardiac hypertrophy and heart failure40,45. We found in our current study that H19 
was gradually downregulated from P1 to P28, suggesting that H19 downregulation could be also involved in the 
transition.
Our study also revealed one previously unreported cardiac-enriched lncRNA, ENSMUST00000117266, 
with higher expression at P1 and downregulated at P28. Co-expression network analysis suggests its potential 
role in the regulation of cardiac development. Hypoxia in vitro, paraquat (ROS inducer) and MI in vivo altered 
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1 0Scientific RepoRts | 7:43485 | DOI: 10.1038/srep43485
ENSMUST00000117266 expression further supports the above hypothesis. Furthermore, siRNA knockdown of 
ENSMUST00000117266 confirmed its role in promoting G0/G1 to G2/M phase transition in cardiomyocytes, 
suggesting ENSMUST00000117266’s role in regulating cardiomyocyte proliferative activity46. Further analy-
ses of the role of ENSMUST00000117266 in developing hearts and postnatal hearts will be performed in both 
loss-of-function and gain-of-function mouse models. Additional biochemical analyses will be needed to validate 
our bioinformatic data. Nevertheless, our study provided an important information of the dynamic changes of 
lncRNA in early postnatal hearts.
In conclusion, our study identified differentially expressed lncRNAs in hearts during the early postnatal 
stage. STC, GO and pathway analysis provided lncRNA clusters that are associated with heart transition from 
hyperplastc to hypertrophic growth. The cardiac-enriched intergenic lncRNA ENSMUST00000117266 is likely 
involved in regulating hyperplastic growth during development. These profiling data helps us to better under-
stand the role of lncRNAs during postnatal heart growth and maturation and provides novel candidate targets for 
potential use in regenerative cardiology in the future.
Materials and Methods
Experimental animals. C57BL/6 J mice were purchased from the Experimental Animal Center of the Third 
Military Medical University (Chongqing, China). The mice were housed in the following conditions: 12-hour 
light/dark cycle, 22–25 °C, periodic air changes and free access to water and food. All experiments performed in 
this study were approved by the local animal ethics committee at Third Military Medical University in accord-
ance with the principles published in the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals (NIH Publication No. 85–23, 1996, revised 2011; available from: www.nap.edu/catalog/5140.html). Mice 
used in this work were anaesthetized by 7% chloral hydrate (350 mg/kg body weight), followed by decapitation, 
and then hearts were quickly removed from the sacrificed mice.
Microarray analysis. Triplicate P1, P7 and P28 mouse hearts acquired from 3 different littermates (Pup 
for each time point in one littermate was randomly selected) were used for profiling both lncRNAs and coding 
mRNAs by using Arraystar Mouse LncRNA Microarray v2.0 (Agilent Technologies). We took the mouse hearts at 
P28 (1 week after lactation), to reduce the influence of lactation on cardiomyocyte proliferation43, instead of using 
P21 as reported previously5. Total RNA was prepared using Trizol® Reagent (Life Technologies). By using random 
hexamer primers, RNA was amplified and transcribed into fluorescent complementary RNA (cRNA) along with 
the whole length of transcripts without 3′ bias. After purification with RNeasy Mini Kit (Qiagen), the labeled 
cRNAs were hybridized on the LncRNA Microarray v 2.0 (8 × 60 K). Microarray was then washed and scanned by 
Agilent Microarray Scanner (Agilent Technologies, p/n G2565BA). Agilent Feature Extraction software (Agilent 
Technologies) was utilized to read and analyze the data. Quantile normalization and subsequent data processing 
were conducted by using the GeneSpring GX v11.5.1 software package (Agilent Technologies). After quantile 
normalization of the raw data, lncRNAs and mRNAs, which meet the requirement that at least 3 out of 12 samples 
have flags in Present or Marginal (“All Targets Value”), were chosen for further data analysis. By using lncRNA 
microarray which has probes for 31,423 lncRNAs totally, 18,158 lncRNAs were detected in all samples, while the 
others showed too low signal intensity to be detected. The gene expression data was then analyzed by the random 
variance model47. LncRNAs and mRNAs, with statistical significance among the three groups, were identified by 
FDR value less than 0.05. Volcano plot filtering and hierarchical clustering were used to characterize the lncRNA 
profiles with fold change ≥ 2.0 and FDR < 0.05. Among the 18,158 lncRNAs, a one-way ANOVA was performed 
between the three indicated time points to identify differentially expressed lncRNAs and mRNAs, which were 
defined as more than 2.0-fold changes between P1, P7 and P28. We divided the differentially expressed lncRNAs 
into 4 categories: P7 vs. P1 up, P28 vs. P7 up; P7 vs. P1 down, P28 vs. P7 down; P7 vs. P1 up, P28 vs. P7 down; P7 
vs. P1 down, P28 vs. P7 up and showed them in hierarchical clustering maps by using the Agilent GeneSpring GX 
software (Agilent Technologies).
STC, hierarchical clustering, GO and pathway analysis of differentially expressed lncRNAs and 
neighboring mRNAs. STC algorithm of gene expression dynamics was utilized to profile the gene expres-
sion time series and identify the most distinct gene clusters at indicated time points48. Due to the different expres-
sion tendencies of the differentially expressed lncRNAs and mRNAs at different time points, we established 16 
unique expression profiles for clustering gene expression of short time-series by utilizing the clustering algorithm, 
which assigned each gene to the mostly matched expression profile model according to the correlation coefficient. 
The clustering algorithm and standard hypothesis test were used to classify and identify the profiles that have 
more significant genes assigned.
To further explore whether the expression of neighboring gene transcripts were correlated with the relative 
expression of lncRNAs, we characterized 59 differentially expressed lncRNAs from 4 categories and their corre-
sponding neighboring coding genes and presented them by heat map as described in microarray analysis part.
GO and pathway analysis based on Kyoto Encyclopedia of Genes and Genomes database were utilized to 
analyze the enrichment of these coding genes located nearby to the differentially expressed lncRNAs in GO items 
and biological signal pathways. Each neighboring gene located nearest to its corresponding lncRNA with 300 
kilobase (kb) was selected.
Real time qRT-PCR. Total RNA was prepared using Trizol® agent (Life Technologies) according to the man-
ufacturer’s instruction by using heart tissue or cardiomyocytes from C57BL/6 J mouse. The cDNA was synthe-
sized from 1 μ g total RNA by using Bestar™ qPCR RT Kit (DBI Bioscience). Real time qRT-PCR was conducted 
by using 2× SyberGreen mixture (DBI Bioscience) on ABI Prism 7700 Sequence Detector (Applied Biosystems). 
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Gapdh or 18S was taken as a housekeeping gene to normalize gene expression by using the classical ΔΔCt method. 
Primers used for each gene were listed in Table 1.
Construction of ENSMUST00000117266 co-expression subnetwork. We conducted the gene 
co-expression subnetwork of ENSMUST00000117266 and genes that have higher interaction coefficient with it 
as published literature described49. The threshold value of Pearson correlation was set to 0.97 to ensure a better 
visual representation. Gene pairs in the subnetwork were measured by the significance of correlation test. K-core 
value was used to separate the large amount of genes into smaller subnetworks, which reflects the relationship 
among the associated genes. Cycle nodes represent genes. Edge linking two nodes means the interaction type 
between two genes. Cycle nodes with different colors represent different k-core values, which mean the power 
of the gene in the co-expression subnetwork. The degree of a gene is defined as the number of other genes that 
interact with it, which is shown by the size of its cycle node.
Seqname Primer sequences (5′-3′)
uc008ffq.1_F GTCATATTGCTGTGTGGAGCC
uc008ffq.1_R TAACAATGACGGCCCTGGGT
uc008kgz.1_F CTTCACCGCTCTGTCTTGGT
uc008kgz.1_R CCTCTGGGGCAATCTGACTC
uc007lay.1_F CCCGCAGACTTGGAGAAAGT
uc007lay.1_R GTTTCGATGGCCTTCATCGC
uc007lgb.1_F TGCCTGATGGCCTTTCTCAG
uc007lgb.1_R CTTTCAGTGATGGGGGCGTA
uc007rjm.1_F CCAGGAAGTCACACCCGTC
uc007rjm.1_R CATTGAGGTACCGGCAGGAG
ENSMUST00000127169_F TTAGGGCGCGGTTGTCTTCT
ENSMUST00000127169_R TGGATTTGGGGCCAGTAGATG
AK047066_F CCTTTCTCCGTGTGGTAGGG
AK047066_R CCTTCTCCGGCTCCAAATGA
ENSMUST00000153057_F GGACGCTTTCAACCAGAGGA
ENSMUST00000153057_R ACGAGCTATACGCAGCTCAC
uc008grn.1_F AGTCTTCTGCCATCAAGCCAA
uc008grn.1_R ATCTCTCCTGAACGACCCAGT
AK009349_F TGCTGTTGGCCGTTTAGTGA
AK009349_R AGACGAGTTGTTCGGGGATG
ENSMUST00000140716_F TGGAGTCCCGGAGATAGCTT
ENSMUST00000140716_R GTTGCCCTCAGACGGAGATG
uc009kob.1_F GCATCGCAAAGGCTGGAAAA
uc009kob.1_R CTCCCCTTTATCCGACCAGC
ENSMUST00000136359_F CACTGTATGCCCTAACCGCT
ENSMUST00000136359_R CCCAACCTCCCTCCCTAGAA
ENSMUST00000117266_F GGAAATGTCCGAAGGAAAGTCAG
ENSMUST00000117266_R CCCTGCACTACAAATCTCCCAAC
ENSMUST00000149974_F CCTCGCTCCACTGACCTTCTA
ENSMUST00000149974_R CCTTTGCTAACTATCCTGCCTTT
Ppp1r1c_F AGCACCTACTGTGCATGTCC
Ppp1r1c_R TGGGCTGTTCCCCGTTTATT
AW112010_F AGTCTTCTGCCATCAAGCCA
AW112010_R ATCTCTCCTGAACGACCCAGT
Sap30l_F CAAGAGCGTAAGGCACCTGT
Sap30l_R TCAGGGATGTCAGCATCGTG
Hand1_F ACATCGCCTACCTGATGGAC
Hand1_R TAACTCCAGCGCCCAGACT
Larp1_F ATTATGCCGACCTGTCTCCC
Larp1_R CCCCACTGAGATCCTTTGGT
Gapdh_F AGGTCGGTGTGAACGGATTTG
Gapdh_R TGTAGACCATGTAGTTGAGGTCA
18S_F CCGCCGCCATGTCTCTAGT
18S_R CTTTCCTCAACACCACATGAGC
Table 1.  Primers used in real time qRT-PCR.
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Isolation, culture and treatment of cardiomyocytes. Neonatal mouse cardiomyocyte culture was 
prepared as described in the literature50. Briefly, hearts from P1 C57BL/6 J mice were excised and ventricles 
were washed, minced (1 mm3) and digested with 0.25% trypsin (Beyotime Institute of Biotechnology). After 
digestion was stopped by complete medium (Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
bovine serum (Life Technologies)), cells were collected by centrifugation and then cultured in complete medium 
with 0.1 mM 5-bromo-2-deoxyuridine (Sigma) at 37 °C at the density of 70,000 cells/cm2 in humidified 5% CO2 
atmosphere for further use. After 48 hours of culture in the complete medium, cardiomyocytes were incubated in 
normoxia (21% O2, 5% CO2) or hypoxia (1% O2, 5% CO2) in a hypoxia chamber (Thermo Fisher Scientific) for 
6 hours at 37 °C.
Transfection with siRNAs or ASOs. We performed siRNA transfection using X-tremeGENE siRNA 
transfection kit according to the manufacturer’s protocol (Roche). Briefly, neonatal mouse cardiomyoyctes were 
transfected with the mixture of three different target-specific ENSMUST00000117266 siRNAs (GenePharma) 
and 10 μ l X-tremeGENE siRNA transfection reagent. For ASO transfection, neonatal mouse cardiomyoyctes were 
transfected with the mixture of ENSMUST00000117266 ASOs (Gene Pharma) modified with phosphorothioates 
and locked nucleic acid using lipofectamine 2000 according to the manufacturer’s protocol (Invitrogen). Scramble 
siRNA or ASO was used as a nonspecific control. After 8 hours of transfection, cells were refreshed with the com-
plete medium and cultured for another 48 hours before harvesting for RNA extraction. The sequences of siRNAs 
and ASOs were shown in Table 2.
Neonatal mouse treatment. C57BL/6 J neonatal mice from one littermate were randomly divided into 
2 groups equally, and were treated with daily paraquat (5 mg/kg, Sigma) or 0.9% saline, respectively, through 
subcutaneous injection from P1 to P3, as described in the ref. 3. Neonatal mouse subcutaneously injected 0.9% 
normal saline for the same time served as control group. 12 hours after the last injection of paraquat or normal 
saline, mice were sacrificed and hearts were harvest for further real time qRT-PCR.
MI. For sham and MI surgery, 12-week-old C57BL/6 J mice were randomly divided into the two groups equally. 
Mice were treated with permanent ligation of the left anterior descending coronary artery or a sham operation51.
Nuclear and cytosolic RNA extraction. Nuclear and cytosolic RNA extractions were performed accord-
ing to the manufacture’s protocol (PARISTM Kit, Life Technologies). Briefly, primary mouse cardiomyocytes were 
washed once with PBS, spun down and resuspended in 300 μ L ice-cold cell fractionation buffer. After incubation 
on ice for 10 min and centrifuged at 500 × g, nuclear and cytosolic fractions were obtained from the supernatant 
and pellet, respectively. Then nuclear pellets were further lysed in cell disruption buffer. Nuclear and cytosolic 
lysates were mixed with equal volume of 2× lysis/binding solution and 100% ethanol. Next, the mixtures were 
applied to the filter cartridge and washed by wash solution. Finally, nuclear and cytosolic RNAs were eluted by 
elution buffer.
Immunoblotting. Nuclear and cytosolic extraction of P1 mouse cardiomyocytes were lysed with RIPA buffer 
(Beyotime) and subjected to immunoblot analysis as described before52–54. Antibodies against LAMIN A and 
GAPDH were purchased from Abcam and Cell Signaling, respectively.
Cell cycle analysis. Cardiomyocytes were washed twice with ice-cold PBS and fixed in 75% ice-cold ethanol 
overnight at 4 °C. Then, the fixed cardiomyocytes were stained with 50 mg/ml propidium iodide (PI) containing 
50 mg/ml RNase A (DNase free) for 30 min at room temperature with protection from light. Data were analyzed 
using Accuri C6 flow cytometry (BD Biosciences) and Flow Jo software, as described previously55.
Statistical analysis. Unpaired or paired Student’ t-test was used to compare two independent or depend-
ent groups, respectively, if they are normally distributed. The T approximation test was used if they are with 
unequal-variance. One-way ANOVA was carried out with an appropriate post hoc test for comparison of multiple 
groups. Fisher’s exact test was used in STC, GO and pathway analysis. Generalized linear models were used in 
the randomized block design with litters as the block factor. All tests were two-sided. A p < 0.05 was considered 
statistically significant. Data are presented as mean ± S.D.
siRNA sequences (5′-3′)
siRNA1_F GCGACUUGUGCCUAACUUUTT
siRNA1_R AAAGUUAGGCACAAGUCGCTT
siRNA2_F GCAUGUUGAUCGCAAUGAATT
siRNA2_R UUCAUUGCGAUCAACAUGCTT
siRNA3_F CCUGACAAUCAUUACGACUTT
siRNA3_R AGUCGUAAUGAUUGUCAGGTT
ASO1 AUGCCUAUUAGGUAUGGCCTT
ASO2 UUCGGAAAUGCCUGUAAGGTT
Table 2.  Sequences of ENSMUST00000117266 siRNAs and ASOs.
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